Mapping the landscape of managed entry agreements: a systematic review of global frameworks, system-level components, and implementation challenges
BackgroundManaged Entry Agreements (MEAs) are pivotal for enabling access to innovative pharmaceuticals while mitigating financial risk and addressing evidence uncertainty. Despite conceptual acceptance, the essential requirements for their design and implementation are poorly documented, posing a c...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-04-01
|
| Col·lecció: | Frontiers in Pharmacology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1803870/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
